The latest announcement is out from Zai Lab Ltd ( (HK:9688) ).
Zai Lab Limited announced the grant of share options, restricted share units, and performance share units under its 2024 Equity Incentive Plan. The grants include 204,650 options to 40 employees, 420,100 restricted share units to 381 employees, and 32,975 performance share units to 4 employees. This initiative is part of the company’s strategy to align employee interests with corporate goals and maintain competitive compensation practices.
More about Zai Lab Ltd
Zai Lab Limited is a biopharmaceutical company incorporated in the Cayman Islands, focused on developing and commercializing innovative medicines. The company operates in the healthcare industry and is listed on the Hong Kong Stock Exchange under the stock code 9688.
YTD Price Performance: 38.52%
Average Trading Volume: 400
Technical Sentiment Signal: Strong Sell
Current Market Cap: €3.82B
For detailed information about 9688 stock, go to TipRanks’ Stock Analysis page.